Showing results (121-130 of 570) with videos related to
Sort By:
Pageof 57
The Lancet. Infectious Diseases|February 27, 2015
β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?Patrick N A Harris, Paul A Tambyah, David L PatersonPatient Education and Counseling|May 26, 2026
'Don't know' as lack of trust: Findings from developing a health research knowledge scaleYiyun Shou, Eshele Anak Libau, Yin Mo, et al.The Journal of Antimicrobial Chemotherapy|September 20, 2013
In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?Sebastiaan J van Hal, Jason A Steen, Björn A Espedido, et al.Journal of Clinical Microbiology|November 28, 2014
A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing Acinetobacter pittii sequence type 119 in AustraliaWitchuda Kamolvit, Petra Derrington, David L Paterson, et al.The Journal of Antimicrobial Chemotherapy|December 17, 2020
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosaBurcu Isler, Patrick Harris, Adam G Stewart, et al.Antimicrobial Agents and Chemotherapy|October 17, 2018
New Treatment Options against Carbapenem-Resistant <i>Acinetobacter baumannii</i> InfectionsBurcu Isler, Yohei Doi, Robert A Bonomo, et al.The American Journal of Tropical Medicine and Hygiene|October 14, 2005
Leptospirosis after recreational exposure to water in the Yaeyama islands, JapanMasashi Narita, Shigeki Fujitani, David A Haake, et al.Critical Care Medicine|July 4, 2008
Antibiotic resistance--what's dosing got to do with it?Jason A Roberts, Peter Kruger, David L Paterson, et al.International Journal of Antimicrobial Agents|September 18, 2013
Ampicillin/sulbactam: its potential use in treating infections in critically ill patientsSyamhanin Adnan, David L Paterson, Jeffrey Lipman, et al.Expert Opinion on Drug Metabolism & Toxicology|July 20, 2010
Pharmacokinetic evaluation of piperacillin-tazobactamYoshiro Hayashi, Jason A Roberts, David L Paterson, et al.Pageof 57